Last reviewed · How we verify
BAY2701250 SC — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
BAY2701250 SC (BAY2701250 SC) — Bayer.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| BAY2701250 SC TARGET | BAY2701250 SC | Bayer | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- BAY2701250 SC CI watch — RSS
- BAY2701250 SC CI watch — Atom
- BAY2701250 SC CI watch — JSON
- BAY2701250 SC alone — RSS
Cite this brief
Drug Landscape (2026). BAY2701250 SC — Competitive Intelligence Brief. https://druglandscape.com/ci/bay2701250-sc. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab